RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
1.790
+0.145 (8.81%)
At close: Oct 22, 2024, 4:00 PM
1.730
-0.060 (-3.35%)
Pre-market: Oct 23, 2024, 4:03 AM EDT
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $62.48 million as of October 23, 2024. Its market cap has decreased by -88.05% in one year.
Market Cap
62.48M
Enterprise Value
-46.63M
1-Year Change
-88.05%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since November 1, 2019, RAPT Therapeutics's market cap has decreased from $270.30M to $62.48M, a decrease of -76.89%. That is a compound annual growth rate of -25.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 57.40M | -93.28% |
| Dec 29, 2023 | 854.70M | 44.33% |
| Dec 30, 2022 | 592.20M | -45.43% |
| Dec 31, 2021 | 1.09B | 123.75% |
| Dec 31, 2020 | 485.00M | -19.54% |
| Dec 31, 2019 | 602.80M | 123.01% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision BioSciences | 63.51M |
| Forian | 63.45M |
| OS Therapies | 62.65M |
| Aerovate Therapeutics | 62.64M |
| Milestone Scientific | 62.60M |
| Theratechnologies | 62.43M |
| Mural Oncology | 62.02M |
| LENSAR | 61.87M |